Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma

doi:10.3748/wjg.14.1394

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 9

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3203)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

287

HTML

2538

Figures (1-2)

189

Tables (1-2)

189

Sum=3203

Mar 7, 2008 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (16)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Mar 7, 2008; 14(9): 1394-1398
Published online Mar 7, 2008. doi: 10.3748/wjg.14.1394

Full Size Figure Download Figure

Figure 1 There are three results in the LOH analysis for M6P/IGF2R in primary hepatocellular carcinoma (HCC). A: Informative HCC without LOH in M6P/IGF2R; B: Informative HCC with LOH in M6P/IGF2R; C: Non-informative HCC.

Citation: Jang HS, Kang KM, Choi BO, Chai GY, Hong SC, Ha WS, Jirtle RL. Clinical significance of loss of heterozygosity for M6P/IGF2R in patients with primary hepatocellular carcinoma. World J Gastroenterol 2008; 14(9): 1394-1398
URL: https://www.wjgnet.com/1007-9327/full/v14/i9/1394.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1394